Implementing FDA’s IVPT Recommendations: A Step-By-Step Illustration

Registration Fees:

$350, in-person attendees - general

$150, in-person attendees - government (must have an email ending in ".gov" in order to register at this rate)

• For in-person attendees, beverages and food for AM and PM breaks will be provided; lunch is not included. For the workshop, pre-ordering for your lunch has now closed. Deadline was April 21st. You will be able to go to the onsite café located in Building III, which is next to Building II (where the workshop will be held) to obtain food and beverages or you are welcome to bring your own lunch.

Dawson's Café
Building III, First Floor

The café and coffee bar feature an array of menu options, including vegan, vegetarian, and gluten-free choices, ensuring there is something to suit everyone's dietary needs and preferences. The café menu includes a variety of hot and cold food options, sweet treats, coffee, tea, specialty drinks, and grab-n-go food items. Coffee, water, and pop will be available throughout each day in the conference room (Ballroom). Snacks will be provided for the AM and PM breaks each day.

Free, virtual attendees

For faculty and students from the University of Maryland, Baltimore; The Universities at Shady Grove; and University of Michigan, the workshop is free for in-person attendance. Other students, please email us for a reduced rate. Please contact us at (info@complexgenerics.org) and indicate which workshop you are interested in.

The workshop will clarify the intent of FDA recommendations for IVPT studies, with step-by-step demonstrations illustrating how IVPT study procedures can be performed in a manner compatible with recommendations in FDA’s Guidance for Industry: In Vitro Permeation Test Studies for Topical Drug Products Submitted in ANDAs. The focus will be on IVPT method procedures that abbreviated new drug application (ANDA) applicants frequently struggle to implement successfully, and the procedures will be demonstrated using different IVPT diffusion cell systems from major manufacturers. Critical considerations to guide investigators during method development, validation, and study conduct will be discussed at each stage. Also, best practices for dealing with issues that arise in different scenarios will be discussed.

Join us in person for an interactive experience featuring hands-on activities with diffusion cell systems from different manufacturers to discuss how different design features could impact how you implement FDA Guidance recommendations. Small group working sessions (only for in-person attendees) will simulate challenges and illustrate how one should navigate decisions during IVPT method development and study design for a hypothetical topical drug product. In person attendees will also have the chance to engage with regulatory, academic, and industry experts to ask questions, learn practical skills, share knowledge, and discuss how to approach challenges you may have experienced with IVPT studies. Virtual attendees will enjoy the convenience of accessing live presentations and panel sessions that discuss procedures illustrated with pre-recorded demonstrations.